Michael Yee
Stock Analyst at UBS
(3.56)
# 2,245
Out of 4,966 analysts
1340
Total ratings
47.3%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRSA Korsana Biosciences | Initiated Coverage: Buy | $55 | $31.91 | +72.39% | 1 | Sep 11, 2026 | |
| JNJ Johnson & Johnson | Initiated Coverage: Buy | $133 → $320 | $265.58 | +20.49% | 2 | Sep 3, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $130 | $91.14 | +42.64% | 8 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $220 → $265 | $203.77 | +30.05% | 8 | Aug 28, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $80 | $63.64 | +25.71% | 6 | Aug 20, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $145 → $175 | $143.93 | +21.59% | 6 | Aug 20, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $150 | $143.97 | +4.19% | 71 | Aug 20, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $585 | $515.44 | +13.50% | 128 | Aug 20, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $80 | $32.89 | +143.24% | 15 | Aug 14, 2026 | |
| TRAX First Tracks Biotherapeutics | Rated: Buy | $65 | $36.44 | +78.38% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $34 | $21.26 | +59.96% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $420 → $440 | $377.35 | +16.60% | 187 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,425 | $1,115.70 | +27.72% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $240 | $217.15 | +10.52% | 172 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $143.72 | +21.76% | 188 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $90 | $59.02 | +52.49% | 6 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $260 | $257.12 | +1.12% | 6 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $53.87 | +41.08% | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 | $27.72 | -2.60% | 8 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $17.89 | +151.54% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.02 | +198.51% | 3 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $37.59 | +33.01% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $10.22 | +340.31% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.41 | +79.59% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.94 | +209.28% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $19.02 | -31.65% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $5.22 | +283.14% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $6.07 | +15.32% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.41 | +105.28% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $28.10 | +60.14% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $55.41 | +8.28% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $21.24 | +135.40% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $24.14 | +44.99% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.78 | +349.44% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $23.99 | +16.72% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $33.14 | +65.96% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $3.5 | $4.27 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.87 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $8.60 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $8 | $2.31 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $13.80 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $56.12 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.7855 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $15 | $7.97 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $29.80 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $2.67 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.24 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.09 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $3.08 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $65.68 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $27.83 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.94 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $47.24 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $502.92 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $781.49 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $9.12 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.66 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $121.47 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $101.95 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $42.98 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $90.96 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $275.56 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $162.29 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.0001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $37.09 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $20.45 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $418.72 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $379.09 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.92 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $5.12 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $82.85 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $3.42 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $150.28 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Korsana Biosciences
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $31.91
Upside: +72.39%
Johnson & Johnson
Sep 3, 2026
Initiated Coverage: Buy
Price Target: $133 → $320
Current: $265.58
Upside: +20.49%
Oruka Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $130
Current: $91.14
Upside: +42.64%
Revolution Medicines
Aug 28, 2026
Reiterated: Buy
Price Target: $220 → $265
Current: $203.77
Upside: +30.05%
Bristol-Myers Squibb Company
Aug 20, 2026
Reiterated: Buy
Price Target: $80
Current: $63.64
Upside: +25.71%
Merck & Co.
Aug 20, 2026
Reiterated: Buy
Price Target: $145 → $175
Current: $143.93
Upside: +21.59%
Moderna
Aug 20, 2026
Reiterated: Hold
Price Target: $45 → $150
Current: $143.97
Upside: +4.19%
Vertex Pharmaceuticals
Aug 20, 2026
Rated: Buy
Price Target: $585
Current: $515.44
Upside: +13.50%
Kodiak Sciences
Aug 14, 2026
Rated: Buy
Price Target: $80
Current: $32.89
Upside: +143.24%
First Tracks Biotherapeutics
Aug 13, 2026
Rated: Buy
Price Target: $65
Current: $36.44
Upside: +78.38%
Aug 7, 2026
Rated: Buy
Price Target: $25 → $34
Current: $21.26
Upside: +59.96%
Aug 5, 2026
Reiterated: Buy
Price Target: $420 → $440
Current: $377.35
Upside: +16.60%
Aug 5, 2026
Reiterated: Buy
Price Target: $1,425
Current: $1,115.70
Upside: +27.72%
Jul 30, 2026
Reiterated: Buy
Price Target: $225 → $240
Current: $217.15
Upside: +10.52%
Jul 28, 2026
Reiterated: Buy
Price Target: $175
Current: $143.72
Upside: +21.76%
Jul 24, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $59.02
Upside: +52.49%
Jul 13, 2026
Rated: Hold
Price Target: $230 → $260
Current: $257.12
Upside: +1.12%
Jun 30, 2026
Reiterated: Buy
Price Target: $76
Current: $53.87
Upside: +41.08%
Jun 23, 2026
Reiterated: Hold
Price Target: $27
Current: $27.72
Upside: -2.60%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $17.89
Upside: +151.54%
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.02
Upside: +198.51%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $37.59
Upside: +33.01%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $10.22
Upside: +340.31%
May 31, 2026
Reiterated: Buy
Price Target: $60
Current: $33.41
Upside: +79.59%
May 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.94
Upside: +209.28%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $19.02
Upside: -31.65%
Mar 5, 2026
Reiterated: Buy
Price Target: $3 → $20
Current: $5.22
Upside: +283.14%
Mar 3, 2026
Reiterated: Hold
Price Target: $10 → $7
Current: $6.07
Upside: +15.32%
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $3.41
Upside: +105.28%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $28.10
Upside: +60.14%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $55.41
Upside: +8.28%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $21.24
Upside: +135.40%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $24.14
Upside: +44.99%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.78
Upside: +349.44%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $23.99
Upside: +16.72%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $33.14
Upside: +65.96%
Jun 25, 2025
Reiterated: Hold
Price Target: $1.5 → $3.5
Current: $4.27
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.87
Upside: n/a
Mar 13, 2025
Reiterated: Buy
Price Target: $24 → $18
Current: $8.60
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $145 → $8
Current: $2.31
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $13.80
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $26
Current: $56.12
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.7855
Upside: n/a
Aug 10, 2021
Reiterated: Hold
Price Target: $45 → $15
Current: $7.97
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $10 → $7
Current: $29.80
Upside: n/a
Dec 21, 2018
Reiterated: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $2.67
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.24
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $5.09
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $3.08
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $65.68
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $27.83
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $6.94
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $47.24
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $502.92
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $781.49
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $9.12
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.66
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $121.47
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $101.95
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $42.98
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $90.96
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $275.56
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $115
Current: $162.29
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.0001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $37.09
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $20.45
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $418.72
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $379.09
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $3.92
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $5.12
Upside: n/a
Aug 5, 2015
Reiterated: Hold
Price Target: $9
Current: $82.85
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $3.42
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $150.28
Upside: n/a
Mar 20, 2012
Reiterated: Buy
Price Target: $28
Current: $0.0008
Upside: n/a